Condition: Erectile Dysfunction Following Radical Prostatectomy · Sponsor: The Netherlands Cancer Institute
The PEHAB-II study is prospective, randomized trial designed to assess the effect of two different rehabilitation strategies on the recovery of erectile function in nerve sparing prostatectomy patients. The two rehabilitation strategies consist of 1)12 months daily doses of 100 mg Sildenafil combined with vacuum device (VED) therapy for 10 minutes a day, five times a week or 2) Standard of care: monotherapy with an on-demand dosage of 100mg Sildenafil. The study will be performed in multiple centers in the Netherlands.
This description comes directly from the study's public registry record.
Inge Cox, MD · 020 - 512 9111 · i.cox@nki.nl
Melianthe Nicolai, MD/PhD · 020 - 512 9111 · m.nicolai@nki.nl
Always discuss trial participation with your own doctor first.
| Canisius Wilhelmina Ziekenhuis | Nijmegen, Gelderland, Netherlands | Not Yet Recruiting |
| Antoni van Leeuwenhoek hospital, Netherlands Cancer Institute | Amsterdam, North Holland, Netherlands | Recruiting |
| Maasstad ziekenhuis | Rotterdam, South Holland, Netherlands | Not Yet Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06875258